tirzepatide no longer shortage FDA declares Mounjaro, Zepbound over Tirzepatide Shortage Resolved: What It

Weight loss drugs are expensive and are covered by some insurance plans, but most people get insurance through their employers, so its a question of whether employers opted in or out of weight loss benefits, says Michelle Pearlman, MD, CEO and co-founder of Prime Institute and ByteMD and a physician who is board-certified in internal medicine, gastroenterology, and obesity medicine

Pancreatitis history requires careful consideration

However, injectable semaglutide (2.4 mg) still produces greater absolute weight loss (14.9% vs 12.4%) and has proven cardiovascular benefit from SELECT, plus years of real-world safety data

"Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial." NEJM, 2023;389:514526